RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer

Clinical Trial ID NCT01149356

PubWeight™ 8.71‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01149356

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol 2015 2.02
2 Emerging targeted agents in metastatic breast cancer. Nat Rev Clin Oncol 2013 1.59
3 Notch inhibitors for cancer treatment. Pharmacol Ther 2013 1.55
4 Therapeutic approaches to modulating Notch signaling: current challenges and future prospects. Semin Cell Dev Biol 2012 1.17
5 A phase II study of RO4929097 in metastatic colorectal cancer. Eur J Cancer 2012 1.05
6 Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer. Cancer Growth Metastasis 2015 0.90
7 Targeted therapy in cancer. Cancer Chemother Pharmacol 2015 0.75
Next 100